STAT+: Biotech venture capitalists have more money than ever to invest. What could possibly go wrong?
There’s more money sloshing around in biotech than ever before.
Over the past year, several trends have converged to create a historic financing environment for startups, full of what industry insiders call “dry powder.”
Continue to STAT+ to read the full story…
